Publicacións en colaboración con investigadores/as de University of Alberta (14)

2020

  1. α-Synuclein strains target distinct brain regions and cell types

    Nature Neuroscience, Vol. 23, Núm. 1, pp. 21-31

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

  2. Full atomistic model of prion structure and conversion

    PLoS Pathogens, Vol. 15, Núm. 7

  3. The prion 2018 round tables (I): the structure of PrPSc

    Prion

2018

  1. The structure of PrP sc prions

    Pathogens, Vol. 7, Núm. 1

  2. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107

2017

  1. Elucidating the structure of an infectious protein

    PLoS Pathogens, Vol. 13, Núm. 4

  2. Somatostatin binds to the human amyloid β peptide and favors the formation of distinct oligomers

    eLife, Vol. 6

  3. The Structure of Mammalian Prions and Their Aggregates

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 277-301

  4. The Structure of the Infectious Prion Protein and Its Propagation

    Progress in Molecular Biology and Translational Science (Elsevier B.V.), pp. 341-359

2016

  1. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis

    QJM, Vol. 109, Núm. 6, pp. 377-382

  2. The Structural Architecture of an Infectious Mammalian Prion Using Electron Cryomicroscopy

    PLoS Pathogens, Vol. 12, Núm. 9

2015

  1. Proteinase K and the structure of PrPSc: The good, the bad and the ugly

    Virus Research, Vol. 207, pp. 120-126

2014

  1. The structure of the infectious prion protein Experimental data and molecular models

    Prion, Vol. 8, Núm. 1